piribedil has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Salvia, M; Jenner, P; Marsden, CD; Smith, L | 1 |
Bezard, E; Bioulac, B; Boraud, T; Gross, CE | 1 |
Bonhomme, C; Braceras, R; Chezaubernard, C; Del Signore, S; Hansard, MJ; Jackson, MJ; Jenner, P; Rose, S; Smith, LA; Tel, BC | 1 |
3 other study(ies) available for piribedil and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
An appraisal of the antiparkinsonian activity of piribedil in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Oral; Animals; Antiemetics; Antiparkinson Agents; Callithrix; Domperidone; Dose-Response Relationship, Drug; Drug Synergism; Female; Locomotion; Male; Motor Skills; Parkinson Disease, Secondary; Piribedil; Premedication; Receptors, Dopamine D2; Stereotyped Behavior | 1996 |
Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Animals; Apomorphine; Dopamine Agonists; Dyskinesia, Drug-Induced; Female; Globus Pallidus; Macaca fascicularis; Neural Pathways; Neurons; Parkinsonian Disorders; Piribedil; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2001 |
Repeated administration of piribedil induces less dyskinesia than L-dopa in MPTP-treated common marmosets: a behavioural and biochemical investigation.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Arousal; Callithrix; Caudate Nucleus; Corpus Striatum; Culture Techniques; Drug Administration Schedule; Dyskinesia, Drug-Induced; Dyskinesias; Female; In Situ Hybridization; Levodopa; Locomotion; Male; Piribedil; RNA, Messenger; Severity of Illness Index; Time Factors | 2002 |